✦ LIBER ✦

W1221 Long-Term Efficacy and Safety of Adalimumab Treatment in a Single-Center Cohort of Crohn's Disease Patients Who Failed to Infliximab Treatment

✍ Scribed by Karmiris, Konstantinos; Noman, Maja; Schnitzler, Fabian; Fidder, Herma; Koutroubakis, Ioannis E.; Kouroumalis, Elias; Vermeire, Severine; Van Assche, Gert A.; Rutgeerts, Paul

Book ID: 122911505
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 82 KB
Volume: 134
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(08)63072-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P052 LONG-TERM EFFICACY AND SAFETY OF AD

P052 LONG-TERM EFFICACY AND SAFETY OF ADALIMUMAB TREATMENT IN A SINGLE-CENTER COHORT OF CROHN' S DISEASE PATIENTS WHO FAILED TO INFLIXIMAB TREATMENT

✍ K. Karmiris; M. Noman; F. Schnitzler; H. Fidder; I.E. Koutroubakis; E.A. Kouroum 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 73 KB

LONG-TERM OUTCOME OF TREATMENT WITH INFL

LONG-TERM OUTCOME OF TREATMENT WITH INFLIXIMAB IN 440 CROHN'S DISEASE PATIENTS: RESULTS FROM A SINGLE CENTER COHORT

✍ F. Schnitzler; H. Fidder; M. Ferrante; M. Noman; G. Van Assche; I. Hoffman; S. V 📂 Article 📅 2007 🏛 Oxford University Press ⚖ 96 KB

Clinical experience with infliximab and

Clinical experience with infliximab and adalimumab in a single-center cohort of patients with Crohn's disease

✍ Riis, Åse; Martinsen, Tom C.; Waldum, Helge L.; Fossmark, Reidar 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 166 KB

MAINTENANCE OF REMISSION WITH INFLIXIMAB

MAINTENANCE OF REMISSION WITH INFLIXIMAB IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS: EFFICACY AND SAFETY LONG-TERM TREATMENT

✍ S. Nasoni; A. Petrolati; N. Altavilla; Z. Rossi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 69 KB

O07 LONG-TERM SAFETY OF INFLIXIMAB IN TH

O07 LONG-TERM SAFETY OF INFLIXIMAB IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: A SINGLE CENTER COHORT STUDY

✍ H. Fidder; F. Schnitzler; M. Ferrante; M. Noman; K. Katsanos; G. Van Assche; S. 📂 Article 📅 2007 🏛 Oxford University Press ⚖ 78 KB

Efficacy and safety of short-term adalim

Efficacy and safety of short-term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: a prospective, open-label, multicentre trial

✍ J. HINOJOSA; F. GOMOLLÓN; S. GARCÍA; G. BASTIDA; J. L. CABRIADA; C. SARO; D. CEB 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 557 KB